773 results on '"Trépo C"'
Search Results
102. P.091 Selection and phenotypic characterization of multiple drug resistant variants in patients with chronic hepatitis B
103. P.016 Successful transfection of macaca Cynomolgus with cloned human hepatitis B virus
104. O.007 The HDV/HepaRG model for in vitro analysis of the HBV envelope protein functions at viral entry
105. O.104 Codelivery of cytokine genes with DNA vaccine to duck hepatitis B virus proteins improves its therapeutic efficacy
106. P.158 Novel interferon alpha variant with improved inhibitory activity against HCV genotype 1 replication compared to IFN alpha-2b therapy, in a subgenomic replicon system
107. P.415 Acute hepatitis B in HIV patients: risk and prevention of chronicity
108. O.075 Evaluation of replication capacity and cross-resistance of HBV drug resistant mutants
109. Virologie de l'hépatite B
110. P.334 HDV genotypes in the western Brazilian Amazon region: a preliminary report
111. P.084 Inhibition of duck hepatitis B virus replication by peptide nucleic acids (PNAs) coupled to a transporter peptide
112. P.064 Spontaneous clearance of HBV markers among HBV carriers from an area of northeastern Brazil where genotype A prevails
113. P.434 Frizzled-7 is commonly expressed by cancerous hepatocytes in virus and non-virus related human hepatocellular carcinomas: correlations with pathological features and β-catenin/p53 mutation status
114. O.157 High dose 3D conformal radiation therapy in cirrhotic patients with small hepatocellular carcinomas
115. P.395 Histological benefit of retreatment by pegylated-IFN and ribavirin in patients with recurrent hepatitis HCV infection post-transplantation
116. P.384 Phase 1 study of intra-arterial hepatic (IAH) delivery of doxorubicin-transdrug® (DT) for patients with advanced hepatocellular carcinoma (HCC)
117. P.389 Epidemiology of hepatocellular carcinoma in Morocco
118. O.085 Overexpression of the Wnt/Frizzled signal's memebers: A strikingly common and early event in human hepatocellular carcinoma (HCC)
119. P.237 Blood distribution of non-phosphorylated and phosphorylated forms of ribavirin in patients treated for chronic hepatitis C
120. P.028 No amplification of the hepatitis B virus covalently closed circular DNA after in vitro infection of the human hepatoma HepaRG cells
121. P.438 Newly referred hepatitis C patients: changes in epidemiological profile over time
122. P.161 Alpha-glucosidase inhibitors prevent the assembly and induce a reduction of HCV infectivity
123. CA5 - Expression différentielle des éléments du complexe Wnt/frizzled dans le carcinome hépatocellulaire (CHC) humain en fonction de l’étiologie virale B (VHB), C (VHC) ou non virale (NBNC)
124. C032 - Réponse histologique chez les malades co-infectés VIH-VHC traités par peginterféron alpha-2a plus ribavirine dans l’étude apricot
125. CA23 - Quelles sont les variables associées à une fibrose sévère (> 3) chez les malades ayant une hépatite chronique virale B
126. CA27 - Observatoire ponts : volonté des soignants et désirs des malades assurent des traitements efficaces des hépatites C chez les toxicomanes
127. Genetic immunization and comprehensive screening approaches in HLA‐A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen
128. CO16 - Importance clinique et thérapeutique des co-infections à VHB occultes au cours des hépatites C chroniques
129. CA12 - Susceptibilité aux analogues de nucléosides d’une souche du VHB résistante a la lamivudine et à l’adéfovir
130. The risk of hospital-acquired GB virus C infection: a pilot case–control study
131. Hepatitis C virus among blood donors: follow-up study.
132. Role of silent hepatitis B virus in chronic hepatitis B surface antigen(−) liver disease
133. 1Infection of primary hepatocytes of Tupaia belangeri by hepatitis C virus
134. Antiviral Activity of β- l -2′,3′-Dideoxy-2′,3′-Didehydro-5-Fluorocytidine in Woodchucks Chronically Infected with Woodchuck Hepatitis Virus
135. L'histoire naturelle de l'infection par le virus de l'hépatite c
136. Expression of Noncovalent Hepatitis C Virus Envelope E1-E2 Complexes Is Not Required for the Induction of Antibodies with Neutralizing Properties following DNA Immunization
137. Recent Dramatic Decrease in AIDS Cases and HIV-Related Deaths Contrasts With Stable Rate of New HIV-Positive Patients Detected in Lyon, France, From 1988 to 1997
138. Ribavirin monotherapy in patients with chronic hepatitis C: a retrospective study of 95 patients
139. Analysis of a hepatitis delta virus isolate from the Central African Republic
140. HCV and lymphoproliferative diseases
141. Rapid detection and clinical significance of mutations in the promoter and the pre-core region of hepatitis B virus genome
142. A novel vector for the study of hepatitis delta virus replication
143. Comparison of HCV RNA assays for the detection and quantification of hepatitis C virus RNA levels in serum of patients with chronic hepatitis C treated with interferon
144. Traitements des hépatites C
145. Antiviral activity of famciclovir therapy on HBV replication in patients with chronic hepatitis B
146. Inhibitory Effect of Penciclovir-Triphosphate on Duck Hepatitis B Virus Reverse Transcription
147. The First Flaviviridae Symposium
148. In vitro inhibition of hepatitis C virus gene expression by chemically modified antisense oligodeoxynucleotides
149. n-Butyrate, a cell cycle blocker, inhibits early amplification of duck hepatitis B virus covalently closed circular DNA after in vitro infection of duck hepatocytes
150. 2',3'-dideoxy-beta-L-5-fluorocytidine inhibits duck hepatitis B virus reverse transcription and suppresses viral DNA synthesis in hepatocytes, both in vitro and in vivo
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.